WASHINGTON, D.C. (AP) -- U.S. regulators have granted accelerated approval to the first in a new class of drugs for ovarian cancer, AstraZeneca PLC's Lynparza....
By The Associated Press, Associated Press: Health
Fri, 12/19/2014 - 11:24am
WASHINGTON, D.C. (AP) -- U.S. regulators have granted accelerated approval to the first in a new class of drugs for ovarian cancer, AstraZeneca PLC's Lynparza....